Guiyang Xintian Pharmaceutical Co.,Ltd. (SHE:002873)
China · Delayed Price · Currency is CNY 10.51
+0.05 (0.48%)
At close: Feb 13, 2026
SHE:002873 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | 7.5 | 52.32 | 80.87 | 111.52 | 100.61 | 74.1 |
Depreciation & Amortization | 36.12 | 36.12 | 23.34 | 25.45 | 22.81 | 19.09 |
Other Amortization | 2.87 | 2.87 | 1.47 | 1.28 | 2.69 | 2.15 |
Loss (Gain) From Sale of Assets | -18.9 | -18.9 | - | 0.02 | 0.1 | - |
Asset Writedown & Restructuring Costs | 0.71 | 0.71 | 0.07 | 0.12 | 0.37 | 0.48 |
Loss (Gain) From Sale of Investments | -0.02 | -0.02 | 0.72 | 0.4 | - | - |
Provision & Write-off of Bad Debts | 2.61 | 2.61 | -0.27 | 0.52 | 1.73 | -0.51 |
Other Operating Activities | 129.44 | 23.33 | 16.11 | 15.23 | 17.52 | 17.95 |
Change in Accounts Receivable | -38.03 | -38.03 | 7 | -20.18 | -8.45 | 37.47 |
Change in Inventory | 35.8 | 35.8 | -1.2 | -66.75 | -40.35 | 7.69 |
Change in Accounts Payable | -10 | -10 | -52.08 | 1.79 | 25.94 | 20 |
Change in Other Net Operating Assets | - | - | - | - | - | 1.6 |
Operating Cash Flow | 149.43 | 88.13 | 77.78 | 75.82 | 124.3 | 175.77 |
Operating Cash Flow Growth | 55.13% | 13.30% | 2.59% | -39.00% | -29.28% | 421.13% |
Capital Expenditures | -41.43 | -61.45 | -101.7 | -129.2 | -105.69 | -68.15 |
Sale of Property, Plant & Equipment | 11.88 | 15.08 | 5 | 0.03 | 0.08 | 1.35 |
Investment in Securities | -40 | 0 | 0 | 50 | -112 | -259.87 |
Other Investing Activities | 0.01 | - | - | - | - | - |
Investing Cash Flow | -69.55 | -46.37 | -96.7 | -79.17 | -217.61 | -326.67 |
Long-Term Debt Issued | - | 680 | 506 | 347 | 273 | 568.3 |
Total Debt Issued | 602.9 | 680 | 506 | 347 | 273 | 568.3 |
Long-Term Debt Repaid | - | -577.29 | -404 | -278 | -418.63 | -236.99 |
Total Debt Repaid | -601.89 | -577.29 | -404 | -278 | -418.63 | -236.99 |
Net Debt Issued (Repaid) | 1.01 | 102.71 | 102 | 69 | -145.63 | 331.31 |
Issuance of Common Stock | - | - | - | - | 27.81 | - |
Repurchase of Common Stock | -129.48 | -129.48 | -2.99 | -3.1 | -15.02 | -2.7 |
Common Dividends Paid | -41.26 | -35.06 | -42.53 | -34.35 | -30.33 | -26.23 |
Other Financing Activities | 122.56 | - | - | - | -1.12 | -3.05 |
Financing Cash Flow | -47.17 | -61.83 | 56.48 | 31.54 | -164.3 | 299.33 |
Foreign Exchange Rate Adjustments | - | - | 0 | - | - | - |
Net Cash Flow | 32.71 | -20.07 | 37.57 | 28.19 | -257.61 | 148.43 |
Free Cash Flow | 107.99 | 26.68 | -23.92 | -53.38 | 18.61 | 107.62 |
Free Cash Flow Growth | 521.54% | - | - | - | -82.71% | - |
Free Cash Flow Margin | 14.30% | 3.11% | -2.51% | -4.91% | 1.92% | 14.33% |
Free Cash Flow Per Share | 0.47 | 0.12 | -0.10 | -0.22 | 0.08 | 0.45 |
Cash Income Tax Paid | 90.27 | 79.86 | 97.63 | 117.84 | 112 | 86 |
Levered Free Cash Flow | 87.1 | -6.5 | -31.37 | -97.92 | -17.28 | 62 |
Unlevered Free Cash Flow | 93.66 | 4.48 | -23.99 | -91.24 | -6.9 | 65.42 |
Change in Working Capital | -10.9 | -10.9 | -44.54 | -78.71 | -21.52 | 62.51 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.